Cultivation of RPMI 2650 cells as an in‐vitro model for human transmucosal nasal drug absorption studies: optimization of selected culture conditions

No abstract is available for this paper.

• Publication year

  2012

• Venue

  The Journal of pharmacy and pharmacology

• Publication date

  2012-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.2042-7158.2012.01540.xPMID 23058049
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improved transnasal transport and brain uptake of tizanidine HCl-loaded thiolated chitosan nanoparticles for alleviation of pain.

  2012cited by this paper
• In vitro cell culture models to study the corneal drug absorption

  2011cited by this paper
• Intranasal delivery of stem cells to the brain

  2011cited by this paper
• Nasal vaccine innovation

  2010cited by this paper
• New strategies to improve the intranasal absorption of insulin.

  2010cited by this paper
• Pharmacokinetics and pharmacodynamics of nasally delivered midazolam.

  2010cited by this paper
• RPMI 2650 epithelial model and three-dimensional reconstructed human nasal mucosa as in vitro models for nasal permeation studies.

  2010cited by this paper
• Development of a serum-free human cornea construct for in vitro drug absorption studies: the influence of varying cultivation parameters on barrier characteristics.

  2010cited by this paper
• Intranasal Delivery of Antiviral siRNA

  2010cited by this paper
• An improved primary human nasal cell culture for the simultaneous determination of transepithelial transport and ciliary beat frequency

  2009cited by this paper
• Nasal Delivery of High Molecular Weight Drugs

  2009cited by this paper
• In Vitro Cellular Models for Nasal Drug Absorption Studies

  2008cited by this paper
• Evaluation of human nasal RPMI 2650 cells grown at an air-liquid interface as a model for nasal drug transport studies.

  2008influential reference
• Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: a randomized, double-blind, double-dummy, two-way, crossover study.

  2008cited by this paper
• In Situ and Ex Vivo Nasal Models for Preclinical Drug Development Studies

  2008cited by this paper
• Spray-dried mucoadhesive microspheres: Preparation and transport through nasal cell monolayer

  2006influential reference
• Air-Liquid Interface Culture of Serially Passaged Human Nasal Epithelial Cell Monolayer for In Vitro Drug Transport Studies

  2005cited by this paper
• The novel use of the human nasal epithelial cell line RPMI 2650 as an in vitro model to study the influence of allergens and cytokines on transforming growth factor‐β gene expression and protein release

  2005cited by this paper
• The use of human nasal in vitro cell systems during drug discovery and development.

  2005cited by this paper
• Permeability of porcine nasal mucosa correlated with human nasal absorption.

  2003cited by this paper
• Serially Passaged Human Nasal Epithelial Cell Monolayer for in Vitro Drug Transport Studies

  2003cited by this paper
• Poly-L-Arginine Predominantly Increases the Paracellular Permeability of Hydrophilic Macromolecules Across Rabbit Nasal Epithelium in Vitro

  2003cited by this paper
• The enhancing effect of nasal absorption of FITC-dextran 4,400 by β-sitosterol β-d-glucoside in rabbits

  2002cited by this paper
• The enhancing effect of nasal absorption of FITC-dextran 4,400 by beta-sitosterol beta-D-glucoside in rabbits.

  2002cited by this paper
• In‐vitro nasal drug delivery studies: comparison of derivatised, fibrillar and polymerised collagen matrix‐based human nasal primary culture systems for nasal drug delivery studies

  2001cited by this paper
• Enhancement of the Systemic and CNS Specific Delivery of L-Dopa by the Nasal Administration of Its Water Soluble Prodrugs

  2000cited by this paper
• In vitro cell models to study nasal mucosal permeability and metabolism.

  1998cited by this paper
• In-vitro Cell Culture Models of the Nasal Epithelium: A Comparative Histochemical Investigation of Their Suitability for Drug Transport Studies

  1996cited by this paper
• Cell culture sheets to study nasal peptide metabolism

  1996cited by this paper
• Evaluation of the human cell line RPMI 2650 as an in vitro nasal model.

  1995cited by this paper
• Development of a Human Nasal Epithelial Cell Culture Model and Its Suitability for Transport and Metabolism Studies Under in Vitro Conditions

  1995cited by this paper
• In vitro permeation of several model drugs across rabbit nasal mucosa

  1994cited by this paper
• Roles of soluble fibronectin and beta 1 integrin receptors in the binding of Mycobacterium leprae to nasal epithelial cells.

  1993cited by this paper
• The Transport Barrier of Epithelia: A Comparative Study on Membrane Permeability and Charge Selectivity in the Rabbit

  1992cited by this paper
• Cell culture approaches to the investigation of human airway ion transport.

  1987cited by this paper
• Abnormal apical cell membrane in cystic fibrosis respiratory epithelium. An in vitro electrophysiologic analysis.

  1987cited by this paper
• Studies of a human tumor cell line with a diploid karyotype

  1964cited by this paper

• Engineered commensals for targeted nose-to-brain drug delivery.

  2025cites this paper
• Polymeric nanoparticles for efficient nose-to-brain delivery.

  2025cites this paper
• Three-dimensional bioprinted gelatin methacryloyl scaffold: a versatile platform for nasal cell culture and drug testing applications.

  2025cites this paper
• In Vitro Evaluation of the Efficient Passage of PLGA-Formulated Trastuzumab for Nose-to-Brain Delivery

  2025cites this paper
• Advances in cell-penetrating peptide-based nose-to-brain drug delivery systems.

  2025cites this paper
• Three-Dimensional Cultured Human Nasal Epithelial Cell Model for Testing Respiratory Toxicity and Neurotoxicity of Air Pollutants.

  2025cites this paper
• Analysis of Polymer/siRNA Nanoparticle Efficacy and Biocompatibility in 3D Air–Liquid Interface Culture Compared to 2D Cell Culture

  2025cites this paper
• Nasal delivery of encapsulated recombinant ACE2 as a prophylactic drug for SARS-CoV-2.

  2024cites this paper
• A Modified Cell-Penetrating Peptide Enhances Insulin and Oxytocin Delivery across an RPMI 2650 Nasal Epithelial Cell Barrier In Vitro

  2024cites this paper
• Using Rapid Prototyping to Develop a Cell-Based Platform with Electrical Impedance Sensor Membranes for In Vitro RPMI2650 Nasal Nanotoxicology Monitoring

  2024cites this paper
• Air-liquid interface (ALI) impact on different respiratory cell cultures.

  2023cites this paper
• The Path from Nasal Tissue to Nasal Mucosa on Chip: Part 2—Advanced Microfluidic Nasal In Vitro Model for Drug Absorption Testing

  2023cites this paper
• The Path from Nasal Tissue to Nasal Mucosa on Chip: Part 1—Establishing a Nasal In Vitro Model for Drug Delivery Testing Based on a Novel Cell Line

  2023cites this paper
• Nasal-PAMPA: a novel non-cell-based high throughput screening assay for prediction of nasal drug permeability.

  2023cites this paper
• Development and Evaluation of an FDM Printed Nasal Device for CPZ Solid Nanoparticles

  2023cites this paper
• The Cultivation Modality and Barrier Maturity Modulate the Toxicity of Industrial Zinc Oxide and Titanium Dioxide Nanoparticles on Nasal, Buccal, Bronchial, and Alveolar Mucosa Cell-Derived Barrier Models

  2023cites this paper
• In vitro Evaluation of Paliperidone Palmitate Loaded Cubosomes Effective for Nasal-to-Brain Delivery

  2023cites this paper
• Optimising nasal powder drug delivery - Characterisation of the effect of excipients on drug absorption.

  2023cites this paper
• Applicability of RPMI 2650 and Calu-3 Cell Models for Evaluation of Nasal Formulations

  2022cites this paper
• Electrospun Mucoadhesive Zein/PVP Fibroporous Membrane for Transepithelial Delivery of Propranolol Hydrochloride.

  2022cites this paper
• Formulation of Chitosan Microparticles for Enhanced Intranasal Macromolecular Compound Delivery: Factors That Influence Particle Size during Ionic Gelation

  2022cites this paper
• Pre-referral intranasal artesunate powder for cerebral malaria: a proof-of-concept study

  2022influential citation
• Antioxidative NAC-Loaded Silk Nanoparticles with Opening Mucosal Tight Junctions for Nasal Drug Delivery: An In Vitro and In Vivo Study

  2022cites this paper
• 3D printed transwell-integrated nose-on-chip model to evaluate effects of air flow-induced mechanical stresses on mucous secretion

  2022cites this paper
• Comparison of RPMI 2650 cell layers and excised sheep nasal epithelial tissues in terms of nasal drug delivery and immunocytochemistry properties.

  2021cites this paper
• Controlled Drug Delivery via the Nasal Route

  2021cites this paper
• Air-liquid interface cultures of the healthy and diseased human respiratory tract: promises, challenges and future directions.

  2021cites this paper
• Development of a microemulsion for encapsulation and delivery of gallic acid. The role of chitosan.

  2020cites this paper
• Permeation enhancement effects of leaf materials from different aloe species on in vitro and ex vivo nasal epithelial models

  2020cites this paper
• Impact of Glycosylation and Species Origin on the Uptake and Permeation of IgGs through the Nasal Airway Mucosa

  2020cites this paper
• In vitro characterization of physico‐chemical properties, cytotoxicity, bioactivity of urea‐crosslinked hyaluronic acid and sodium ascorbyl phosphate nasal powder formulation

  2019cites this paper
• A 3D “In Vitro” Model to Study Hyaluronan Effect in Nasal Epithelial Cell Line Exposed to Double-Stranded RNA Poly(I:C)

  2019cites this paper
• Suitability of RPMI 2650 cell models for nasal drug permeability prediction.

  2019cites this paper
• Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650

  2019cites this paper
• Mixed Mucoadhesive Amphiphilic Polymeric Nanoparticles Cross a Model of Nasal Septum Epithelium in Vitro.

  2019cites this paper
• How to characterize a nasal product. The state of the art of in vitro and ex vivo specific methods

  2019cites this paper
• Pharmacological Characterization of the RPMI 2650 Model as a Relevant Tool for Assessing the Permeability of Intranasal Drugs.

  2018cites this paper
• Expression analysis of human solute carrier (SLC) family transporters in nasal mucosa and RPMI 2650 cells

  2018cites this paper
• Development and Evaluation of a Novel Intranasal Spray for the Delivery of Amantadine Journal Item

  2018cites this paper
• Is RPMI 2650 a Suitable In Vitro Nasal Model for Drug Transport Studies?

  2017cites this paper
• Development of a Soluplus budesonide freeze-dried powder for nasal drug delivery

  2017cites this paper
• Activity of Multidrug Resistance-Associated Proteins 1-5 (MRP1-5) in the RPMI 2650 Cell Line and Explants of Human Nasal Turbinate.

  2017cites this paper
• Cell-based in vitro models for nasal permeability studies

  2016cites this paper
• Investigation of betahistine dihydrochloride biocompatibility and nasal permeability in vitro

  2016cites this paper
• Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products.

  2016cites this paper
• Effect of High, Medium, and Low Molecular Weight Hyaluronan on Inflammation and Oxidative Stress in an In Vitro Model of Human Nasal Epithelial Cells

  2016cites this paper
• Expression of P-glycoprotein in excised human nasal mucosa and optimized models of RPMI 2650 cells.

  2016cites this paper
• Pharmaceutics, Drug Delivery and Pharmaceutical Technology Development and Evaluation of a Novel Intranasal Spray for the Delivery of Amantadine

  2016cites this paper
• Development and Evaluation of a Novel Intranasal Spray for the Delivery of Amantadine.

  2016cites this paper
• Cytotoxic Activity of Pyrovalerone Derivatives, an Emerging Group of Psychostimulant Designer Cathinones

  2016cites this paper
• Challenges in nasal drug absorption: how far have we come?

  2016cites this paper
• Cell Culture Models for Drug Transport Studies

  2016cites this paper
• Tissue-based in vitro and ex vivo models for nasal permeability studies

  2016cites this paper
• Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs.

  2016influential citation
• Biotransformation in vitro: An essential consideration in the quantitative in vitro-to-in vivo extrapolation (QIVIVE) of toxicity data.

  2015cites this paper
• Human parainfluenza virus type 3 (HPIV3) induces production of IFNγ and RANTES in human nasal epithelial cells (HNECs)

  2015cites this paper
• The characterization of the human cell line Calu-3 under different culture conditions and its use as an optimized in vitro model to investigate bronchial epithelial function.

  2015cites this paper
• The Characterization of the Human Nasal Epithelial Cell Line RPMI 2650 Under Different Culture Conditions and Their Optimization for an Appropriate in vitro Nasal Model

  2015cites this paper
• Reconstituted Human Upper Airway Epithelium as 3-D In Vitro Model for Nasal Polyposis

  2014cites this paper
• Drug transporters in the nasal epithelia and their contribution in drug delivery

  2014cites this paper
• In vitro mimicking of estrous cycle stages based on a comprehensive porcine oviduct epithelial cell culture model

  2013cites this paper